Reckitt Benckiser, the consumer goods giant that makes Nurofen and Dettol, plans to spin off its US-based pharmaceutical business.
Read the full story

Rumour mill has it that Siemens is reportedly investigating a spinout of its Siemens Healthcare division's IT unit, which could be worth more than $1 billion. Read the full story

Big Pharma, Baxter International announced plans to create two separate, independent global healthcare companies -- one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Read the full story

Merck & Co considering a break off of their animal-health and consumer product division, which could boost their share hold value by $50 billion. Read the full story

A new generation of drug industry chief executives is stepping up plans to restructure their businesses by divesting slower-growing and maturing operations, opening up new opportunities for deal-makers Read the full story

NovaQuest Capital Management has closed pharma deals on $80 million in private placement financing. Read the full story

The announcement that GSK intends to create a separate division around its mature brands sparks spin off speculation Read the full story

Three Scottish universities have agreed  in a new financing of £50m Edinburgh-based venture capital fund designed to fund fledgling life science companies spun out of academia across the UK Read the full story

Merck Serono, a top big pharma company announced the creation of Prexton Therapeutics, the first spin-off company resulting from its Entrepreneur Partnership Program launched in April 2012.

Read the full story

Biomet, a biomedical instrument manufacturer decides to explore options for spinning out its 3i dental devices division, following Abbott's lead and Goldman Sachs' advice to another device maker Read the full story